EMD Serono Inc and The University of Texas MD Anderson Cancer Center announce collaboration for pre-clinical research, clinical trials.

EMD Serono Inc and The University of Texas MD Anderson Cancer Center (MD Anderson) announced a strategic alliance designed to provide MD Anderson with early insight into potential cancer treatments and to accelerate EMD Serono's pre-clinical and early clinical research to ultimately bring new drugs to patients faster. The agreement is set for three years with the potential to renew the alliance. This non-exclusive strategic alliance will collaboratively draw on the expertise and resources of MD Anderson and EMD Serono to help design and conduct …